Browsing Tag
psilocin
2 posts
Entropy Neurodynamics moves TRP-8803 into Cohort 2 as ASX:ENP awaits July data
Find out how Entropy Neurodynamics’ DSMB clearance for TRP-8803 could shape ASX:ENP’s next psychedelic medicine catalyst.
June 15, 2026
Entropy Neurodynamics (ASX: ENP) hits TRP-8803 trial milestone as IV psilocin approach draws patient momentum
Entropy Neurodynamics (ASX: ENP) completes Cohort 1 recruitment for its TRP-8803 IV psilocin BED trial. Here's what the milestone means for investors. Read more.
March 3, 2026